Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings Of The Fortnight: Movetis Files First European Biopharma IPO Since Early 2008

This article was originally published in The Pink Sheet Daily

Executive Summary

Notable biotech financings in November also include ThromboGenics, NicOx: 4SC AG, and Fate Therapeutics.

You may also be interested in...



Zealand Pharma Will Test European IPO Market

The Danish biotech hopes to tempt investors with revenue prospects from its late-stage GLP-1 analog, partnered with Sanofi-Aventis.

Zealand Pharma Will Test European IPO Market

The Danish biotech hopes to tempt investors with revenue prospects from its late-stage GLP-1 analog, partnered with Sanofi-Aventis.

Shire Emphasizes The GI Space In Its Bid For Movetis

Only five years ago, Shire's specialty pharma business consisted of one product, Adderall XR, one market, the U.S., and one patient type - children. Multiple generics companies had filed ANDAs, however, and the company was looking to broaden its base

Related Content

Topics

UsernamePublicRestriction

Register

ID014775

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel